Determining the Efficacy of Essential Oil Aromatherapy in Children Undergoing Port Access
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Stanford University
- Enrollment
- 23
- Locations
- 1
- Primary Endpoint
- Effect of aromatherapy on post patient anxiety scores
Study Overview
Brief Summary
The purpose of this study is to determine if the use of aromatherapy impacts patient anxiety and pain scores surrounding port access in pediatric oncology patients between the ages of 4 years and 18 years.
Detailed Description
Specific aims include the following:
Aim 1: To compare pre and post port access anxiety scores for both control and intervention groups.
Aim 2: To assess pre and post port pain scores surrounding port access for both control and intervention groups.
Aim 3: To compare pain and anxiety scores between age groups. The overall goal of this pilot study is to identify if aromatherapy, using non-topical, STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents, is effective as a valid non-pharmacologic supplementation in reducing anxiety and pain scores during port access in pediatric oncology patients.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 4 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Children between 4 years and 18 years
- •Scheduled for port access with or without lab draw
- •Oncology, neuro-oncology, and stem cell transplant patients
Exclusion Criteria
- •has asthma, reactive airway disease, or allergies to any of the ingredients we are using in the aromatherapy study (lavender, bergamot, sweet orange, and ylang ylang)
- •currently uses aromatherapy for port accesses or other painful procedures (does not apply to patients using aromatherapy, such as peppermint oil, for nausea)
- •has a cognitive impairment that prevents them from being able to provide anxiety or pain scores
- •does not wish to participate in the study
Arms & Interventions
Aromatherapy
Patients will be given STILL QuickTAB Medipack blended scent aromatherapy in addition to standard supportive measures, which include numbing cream, Child Life support, distraction, caregiver hold, or any combination of these, based on patient preference.
Intervention: STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents (Other)
Control Group
Participants will be offered standard supportive measures, which include numbing cream, Child Life support, distraction, caregiver hold, or any combination of these, based on patient preference.
Outcomes
Primary Outcomes
Effect of aromatherapy on post patient anxiety scores
Time Frame: 5 minutes
Comparison of pre and post patient anxiety scores for both control and intervention groups using the Visual Facial Anxiety Scale with corresponding values ranging from 0-10. 0 indicates no anxiety and 10 indicates the highest level of anxiety. Anxiety score will be measured by using the Visual Facial Anxiety Scale (VFAS)
Secondary Outcomes
- Effect of aromatherapy on post patient port pain scores(up to 7 minutes)
Investigators
Annette Nasr
Nurse Scientist Nursing Research and Evidence-Based Practice
Stanford University